Alex M. Brill

Mr. Alex Brill has a broad range of public policy expertise and experience including tax, pension, trade, budget and health policy matters. Mr. Brill formerly served as the Policy Director and Chief Economist to the House Committee on Ways and Means and oversaw a broad portfolio of legislative matters in addition to assisting then Chairman Bill Thomas (R-CA) with negotiations with House and Senate leadership offices as well as Senate Finance Committee members.

Prior to his tenure at the Ways and Means Committee, Mr. Brill was an economist at the White House Council of Economic Advisers (CEA), where he provided advice and analyses on national and international economic policies for the President. In 2010, Mr. Brill served as a consultant advisor to the President’s Fiscal Commission (Bowles-Simpson Commission). He also currently serves as a research fellow at the American Enterprise Institute.

Mr. Brill’s health policy focus includes reimbursement matters related to the physician fee schedule, the FDA drug approval process, biosimilars, and Medicare Part B pricing. Mr. Brill’s health policy research includes an investigation of overspending on multi-source drugs in Medicaid, optimal exclusivity policy for biologics drugs, and the consequences of certain taxes and fees within the Affordable Care Act.

He has served as an expert witness in a number of patent litigation cases, testified before Congress on numerous occasions including before the House Committee on Judiciary regarding biologics and regularly appears in the media to discuss the economy and pending federal legislation.

Mr. Brill is the Economic Policy Advisor of Hooper, Lundy & Bookman's Government Relations and Public Policy department. He has a B.A. in Economics from Tufts University and an M.A. in Mathematical Finance from Boston University.

Presentations & Speaking Engagements

News

Health Care Reform

Health Law Perspectives

Other Publications

Publications

"Sequestration's uniform Medicare cut will yield disparate impacts across providers," (with Brett Leitner) The Health Lawyer. (June, 2013).

"Medicare savings the Obama budget plan overlooks," Real Clear Markets. (April 2013).

"The encroaching fiscal cliff: Health care edition," Real Clear Markets. (September 2012).

"Health Policy 101," AEI, Healthcare Reform, contributing author. (June, 2012).

"More Than One Way to Save on Medicaid," State Journal Register. (April, 2012).

"Recognizing the Promise of Vaccines: Public Policy Must Adapt to New Innovations," AEI. (June, 2011).

"Please Actually Read My Research," The American. (April, 2011).

"Saving on Multi-Source Drugs in Ohio's Medicaid Program," Ohio House Health and Human Services Subcommittee. (April, 2011).

"Overspending on Multi-Source Drugs in Medicaid," AEI Online. (March, 2011).

"Another Obama Tax Hike," Wall Street Journal, Healthcare Reform, contributing author. (February, 2010).

"Hitting the Sick in the Wallet," The American. (November, 2009).

"Taxing the Sick: How "Fees" in Health Care Reform Hurt Patients," AEI Online. (October, 2009).

"Statement Before the Judiciary Committee," House Committee on the Judiciary. (July, 2009).

"A Fat Tax That's Hard to Swallow," The American, contributing author. (June, 2009).

"I Pay, You Pay, Variable Co-Pay," AEI, Health, contributing author. (July, 2007).